Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000781130 | SCV000918982 | uncertain significance | not specified | 2017-12-21 | criteria provided, single submitter | clinical testing | Variant summary: The BRCA2 c.8531A>C (p.Glu2844Ala) variant involves the alteration of a conserved nucleotide located in the Tower domain of the protein (InterPro). 4/5 in silico tools predict a damaging outcome for this variant. This variant is absent in 245916 control chromosomes. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available. |
Gene |
RCV004719984 | SCV005326191 | uncertain significance | not provided | 2024-02-26 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Also known as 8759A>C; This variant is associated with the following publications: (PMID: 12228710) |